← Leaderboards
Janice B Schwartz
Northwestern University
$4,527,322
Attributed
$4,797,616
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $780.6K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,327,229 · 10
FDA$470,387 · 1
By mechanism
R01$2,220,865 · 2
R21$980,423 · 2
RC1$831,981 · 1
U01$470,387 · 1
R56$225,000 · 1
M01$68,960 · 4
Top collaborators
- Margaret C. Fang3 shared
Most similar at Northwestern University
Same institution · by research overlap
- Gary L Aistrup$828,161
- Lauren M. Pachman$3,839,960
- Dennis A Twombly$268,445
Others in their field
Top investigators on “Elderly”
- Charles A Coltman · Southwest Oncology Group$158,376,564
- Richard L Schilsky · University Of Chicago$122,071,723
- Michael W Weiner · Northern California Institute Res &Educ$99,760,701
- Monica M Bertagnolli · Strang Cancer Prevention Center$99,246,201
- Richard Mayeux · Columbia University Health Sciences$83,247,500
- Peter Gordon Gillespie · Oregon Health And Science University$80,983,248
Research focus
ElderlyAgingPharmaceutical PreparationsVerapamilWomanOralInvestigationCharacteristicsOlder PatientDrug MetabolismDosageDrug ClearanceHuman SubjectAmlodipineNursing HomesCytochrome P450AlgorithmsClearance RateCyp3a4 GeneMedicalGender DifferenceClinical ResearchDrug KineticsKidney
Grant awards (27)
The study: LatinX/HIspanic Attitudes and Perspectives on Investigations and Studies- of New Drugs: LAPIS-ND$470,387
U01 · FY2022 · FD · contact PI
Direct-Acting Oral Anticoagulants: Anticoagulant Activity in Understudied Older NVAF Patients$161,500
R21 · FY2021 · AG · contact PI
Supplement to Direct-Acting Oral Anticoagulants: Anticoagulant Activity in Understudied Older NVAF Patients$96,900
R21 · FY2021 · AG · contact PI
Direct-Acting Oral Anticoagulants: Anticoagulant Activity in Understudied Older NVAF Patients$282,188
R21 · FY2020 · AG · contact PI
Optimizing vitamin D in the elderly$148,444
R21 · FY2013 · AG · contact PI
Optimizing vitamin D in the elderly$69,141
R21 · FY2013 · AG · contact PI
Optimizing vitamin D in the elderly$222,250
R21 · FY2012 · AG · contact PI
Improving Medication Therapy for Older Patients with Common Co-morbidities$417,338
RC1 · FY2010 · AG · contact PI
Older Persons & Drugs: race, gender, and age effects$225,000
R56 · FY2010 · AG · contact PI
Improving Medication Therapy for Older Patients with Common Co-morbidities$414,643
RC1 · FY2009 · AG · contact PI
Older Persons & Drugs: race, gender, and age effects$237,462
R01 · FY2009 · AG · contact PI
Older Persons & Drugs: race, gender, and age effects$128,500
R01 · FY2009 · AG · contact PI
Older Persons & Drugs: race, gender, and age effects$236,296
R01 · FY2008 · AG · contact PI
Older Persons & Drugs: race, gender, and age effects$239,965
R01 · FY2007 · AG · contact PI
Older Persons & Drugs: race, gender, and age effects$245,978
R01 · FY2006 · AG · contact PI
Older Persons &Drugs: race, gender, and age effects$250,750
R01 · FY2005 · AG
OLDER PERSONS AND DRUGS: RACE, GENDER AND AGE EFFECTS$936
M01 · FY2005 · RR
Older Persons &Drugs: Race, Gender &Age Effects$27,076
M01 · FY2004 · RR
OLDER PERSONS AND DRUGS--RACE, GENDER, AND AGE EFFECTS$223,171
R01 · FY2003 · AG
OLDER PERSONS AND DRUGS--RACE, GENDER, AND AGE EFFECTS$217,606
R01 · FY2002 · AG
OLDER PERSONS AND DRUGS--RACE, GENDER, AND AGE EFFECTS$212,179
R01 · FY2001 · AG
EFFECTS OF AGING AND GENDER ON CYTOCHROME P450 ACTIVITY--SUSTAINED RELEASE DOSE$0
M01 · FY2001 · RR
OLDER PERSONS AND DRUGS--RACE, GENDER, AND AGE EFFECTS$206,891
R01 · FY2000 · AG
CARDIOPULMONARY TIME SERIES ANALYSIS--DRUG AND AGING EFFECTS$22,067
R01 · FY2000 · GM
EFFECT OF AGING AND GENDER ON CYTOCHROME P450 ACTIVITY$20,474
M01 · FY2000 · RR
OLDER PERSONS AND DRUGS--CALCIUM BLOCKER KINETICS/DYNAMICS$20,474
M01 · FY2000 · RR
EFFECTS OF AGING AND GENDER ON CYTOCHROME P450 ACTIVITY--SUSTAINED RELEASE DOSE$0
M01 · FY2000 · RR